Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus
- 30 June 1996
- Vol. 14 (8), 799-810
- https://doi.org/10.1016/0264-410x(95)00229-t
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Update on the neutralisation of animal virusesReviews in Medical Virology, 1995
- Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding siteAIDS, 1995
- hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120AIDS, 1993
- PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a Phase I trial of hyperimmune porcine immunoglobulin to HIV-1AIDS, 1992
- Vaccine Protection of Chimpanzees Against Challenge with HIV-1-Infected Peripheral Blood Mononuclear CellsScience, 1992
- Neutralization of human immunodeficiency virusReviews in Medical Virology, 1992
- Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibodyNature, 1992
- Neutralizing Antibodies Against HIV-1 BRU and SF2 Isolates Generated in Mice Immunized with Recombinant Vaccinia Virus Expressing HIV-1 (BRU) Envelope Glycoproteins and Boosted with Homologous gp160AIDS Research and Human Retroviruses, 1991
- Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160Nature, 1990
- MOTHER-TO-INFANT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1: ASSOCIATION WITH PREMATURITY OR LOW ANTI-gp120The Lancet, 1989